Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals

• Główni autorzy: Yanmei Liu (Autor), Sylvie Retout (Autor), Vincent Duval (Autor), Jingying Jia (Autor), Yang Zou (Autor), Yijun Wang (Autor), Valérie Cosson (Autor), Sébastien Jolivet (Autor), Stefan De Buck (Autor)
• Format: Książka
• Wydane: Wiley, 2022-05-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Baloxavir marboxil is an endonuclease inhibitor indicated for the treatment of influenza in patients ≥12 years. No data exist for Chinese patients in global studies. This randomized, open‐label, phase I study evaluated the pharmacokinetics (PK) and safety of baloxavir marboxil in healthy Ch...